Počet záznamov: 1
rituximab
SYS d000069283 LBL 00000nx^^^2200181-^^45^^ 005 20240119201331.2 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a rituximab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2016 (1995) $8 eng 330 1-
$a A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. $8 eng 450 $a CD20 protilátka, rituximab $5 e $8 slo 450 $a IDEC-C2B8 protilátka $5 e $8 slo 450 $a GP2013 $5 e $8 slo 550 $3 sllk_un_auth*d018951 $Y Antigens, CD20 $5 F $a antigény CD20 550 $3 sllk_un_auth*d018951 $Y Antigens, CD20 $5 B $a antigény CD20 686 $a D12.776.124.486.485.114.224.075.785 686 $a D12.776.124.790.651.114.224.075.785 686 $a D12.776.377.715.548.114.224.284.785 750 $a Rituximab $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160211 980 $x M
Počet záznamov: 1